Short answer
MADRIGAL PHARMACEUTICALS, INC. (MDGL) filed an 8-K current report with the SEC on April 28, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Board reclassified Julian C. Baker and Daniel J. Brennan into Class I effective April 22, 2026.
MADRIGAL PHARMACEUTICALS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Board reclassified Julian C. Baker and Daniel J. Brennan into Class I effective April 22, 2026
- Administrative reclassification to equalize three director classes, not a change in board membership
- Committee assignments unchanged; service deemed uninterrupted
- Baker, Brennan, and James Daly nominated for re-election at June 17, 2026 annual meeting
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other MADRIGAL PHARMACEUTICALS, INC. 8-K filings
Get the next MDGL 8-K as it lands
Follow MDGL for push alerts, or ask the research agent what this filing means.